Rebecca Mathew

Rebecca Mathew

Company: Merck & Co

Job title: Principal Scientist, Discovery Biology

Seminars:

Panel Discussion: Evaluation of the Current State of Play of Preclinical In Vitro Models 10:00 am

Comparing the benefits of in vitro microglia (iMGs), organoid microglia (oMGs), and xenotransplanted microglia (xMGs) Evaluating existing in vitro systems for modelling neuroinflammation and neurological disorders in humans Exploring future implications for advanced preclinical model developmentRead more

day: Conference Day One

Developing an iPSC-derived Human Microglia Platform to Engineer & Enable a Genetically Enriched Neuroimmune Pipeline 9:00 am

Deciphering the information that can be obtained from neuroimmune iPSC-derived models Applying CRISPR screens to evaluate the functional consequences of genetic perturbations in iPSC-derived human microglia Developing a scalable high-throughput iPSC-derived model system for target validationRead more

day: Conference Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.